Stephen Brannan
2020
In 2020, Stephen Brannan earned a total compensation of $3.5M as Chief Medical Officer at Karuna Therapeutics, a 239% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,000 |
|---|---|
| Option Awards | $2,868,283 |
| Salary | $440,000 |
| Other | $8,550 |
| Total | $3,492,833 |
Brannan received $2.9M in option awards, accounting for 82% of the total pay in 2020.
Brannan also received $176K in non-equity incentive plan, $440K in salary and $8.6K in other compensation.
Rankings
In 2020, Stephen Brannan's compensation ranked 3,317th out of 13,090 executives tracked by ExecPay. In other words, Brannan earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,317 out of 13,090 | 75th |
Division Manufacturing | 1,286 out of 5,624 | 77th |
Major group Chemicals And Allied Products | 484 out of 2,257 | 79th |
Industry group Drugs | 419 out of 1,957 | 79th |
Industry Pharmaceutical Preparations | 313 out of 1,462 | 79th |
Source: SEC filing on April 27, 2021.
Brannan's colleagues
We found three more compensation records of executives who worked with Stephen Brannan at Karuna Therapeutics in 2020.